<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(3)</volume><submitter>Wang CH</submitter><funding>the National Health Research Institutes, Taiwan</funding><pubmed_abstract>&lt;h4>Purpose&lt;/h4>This study investigated the short- and long-term use of medication for psychological distress after the diagnosis of cancer.&lt;h4>Methods&lt;/h4>Longitudinal data from the Taiwan National Health Insurance database were used to follow 35,137 cancer patients for 2.5 years after being diagnosed in 2006 and 2007.&lt;h4>Results&lt;/h4>Among those patients who survived for at least 180 days, 20.9 % had used psychotropic medications; sedatives were the most frequently prescribed (14.3 %), followed by antidepressants (5.5 %), anxiolytics (3.6 %), and antipsychotics (2.7 %). Lung cancer, prostate cancer, and oral cancer showed a significant association with the regular use of medication in the first 180 days. Among patients who survived for at least 2.5 years, 4.8 % still used psychotropic med</pubmed_abstract><journal>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</journal><pagination>757-768</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5266776</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Short- and long-term use of medication for psychological distress after the diagnosis of cancer.</pubmed_title><pmcid>PMC5266776</pmcid><pubmed_authors>Chen CL</pubmed_authors><pubmed_authors>Yang CC</pubmed_authors><pubmed_authors>Wang CH</pubmed_authors><pubmed_authors>Yang WC</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Chen YY</pubmed_authors><pubmed_authors>Huang LC</pubmed_authors><pubmed_authors>Chou YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Short- and long-term use of medication for psychological distress after the diagnosis of cancer.</name><description>&lt;h4>Purpose&lt;/h4>This study investigated the short- and long-term use of medication for psychological distress after the diagnosis of cancer.&lt;h4>Methods&lt;/h4>Longitudinal data from the Taiwan National Health Insurance database were used to follow 35,137 cancer patients for 2.5 years after being diagnosed in 2006 and 2007.&lt;h4>Results&lt;/h4>Among those patients who survived for at least 180 days, 20.9 % had used psychotropic medications; sedatives were the most frequently prescribed (14.3 %), followed by antidepressants (5.5 %), anxiolytics (3.6 %), and antipsychotics (2.7 %). Lung cancer, prostate cancer, and oral cancer showed a significant association with the regular use of medication in the first 180 days. Among patients who survived for at least 2.5 years, 4.8 % still used psychotropic med</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Mar</publication><modification>2025-04-04T08:54:16.721Z</modification><creation>2019-03-27T02:35:00Z</creation></dates><accession>S-EPMC5266776</accession><cross_references><pubmed>27785583</pubmed><doi>10.1007/s00520-016-3456-z</doi></cross_references></HashMap>